Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime-avibactam versus cefepime in children with complicated urinary tract infection
2014-003244-13Phase 2Completed
- Sponsor
- Pfizer
- Start
- Feb 2015
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in complicated urinary tract infection (cUTI) comparing Ceftazidime-avibactam with Cefepime (2 arms). Primary endpoint: Safety and tolerability. Started Feb 2015; status: completed.
02
Drugs
ceftazidime + avibactamcefepime
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on 2014-003244-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003244-13.